Silver Book Fact

The total economic burden of coronary heart disease is $120.6 billion; of stroke is $48.9 billion.

Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • In 2009, 372,000 hospitalizations had hypertension listed as the first diagnosis.  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  • Depression and anxiety in AFib patients
    Around 1/3 of atrial fibrillation patients have elevated levels of depression and anxiety.  
  • Within one year of a first myocardial infarction 18% of men and 23% of women, 40 years and older, will die.  
  • Annual AFib-related stroke Medicare costs
    Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional…